APA (7th ed.) Citation

JULAEHA, J., ATHIYAH, U., YULIANA, V., AYUNINGTYAS, J. P., & HERMANSYAH, A. (2021). Schizophrenia, Metabolic Syndrome and the Opportunity for developing Pharmacist-led Toolkit for Education and Metabolic Syndrome Screening (EMESYS): A Review. International Journal of Pharmaceutical Research (09752366), 13(2), 3407. https://doi.org/10.31838/ijpr/2021.13.02.154

Chicago Style (17th ed.) Citation

JULAEHA, JULAEHA, UMI ATHIYAH, VERRA YULIANA, J. P. AYUNINGTYAS, and ANDI HERMANSYAH. "Schizophrenia, Metabolic Syndrome and the Opportunity for Developing Pharmacist-led Toolkit for Education and Metabolic Syndrome Screening (EMESYS): A Review." International Journal of Pharmaceutical Research (09752366) 13, no. 2 (2021): 3407. https://doi.org/10.31838/ijpr/2021.13.02.154.

MLA (9th ed.) Citation

JULAEHA, JULAEHA, et al. "Schizophrenia, Metabolic Syndrome and the Opportunity for Developing Pharmacist-led Toolkit for Education and Metabolic Syndrome Screening (EMESYS): A Review." International Journal of Pharmaceutical Research (09752366), vol. 13, no. 2, 2021, p. 3407, https://doi.org/10.31838/ijpr/2021.13.02.154.